AnaptysBio Inc
ANAB
NASDAQ
Biotechnology
$58.47
USD
+2.45 (+4.37%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.69B
Volume 330.8K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SRPT | Sarepta Therapeutics Inc | $1.94B | - | -20.4% | - | |
ZYME | Zymeworks Inc | $1.79B | - | +3.3% | - | |
RXRX | Recursion Pharmaceuticals Inc | $1.76B | - | -15.1% | - | |
SNDX | Syndax Pharmaceuticals Inc | $1.74B | - | +222.7% | - | |
XNCR | Xencor Inc | $1.72B | - | -33.2% | - | |
ANAB | AnaptysBio Inc | $1.69B | - | +107.7% | - | |
NTLA | Intellia Therapeutics Inc | $1.67B | - | +12.6% | - | |
TRAX | First Tracks Biotherapeutics Inc | $1.67B | - | - | - | |
FBRX | Forte Biosciences Inc | $1.57B | - | -99.8% | - | |
TYRA | Tyra Biosciences Inc | $1.57B | - | - | - |
Top Peer by Growth
Syndax Pharmaceuticals Inc
+222.7% YoY Revenue
Best 1-Year Return
Forte Biosciences Inc
+627.1% Return